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Challenges in Estimating the Causal Effect of
an Intervention with Pre-Post Data (Part 1):
Definition & Identification of the Causal
Parameter
Ann M. Weber, Mark J. van der Laan, and Maya L. Petersen
Abstract
There is mixed evidence of the effectiveness of interventions operating on a large
scale. Although the lack of consistent results is generally attributed to problems
of implementation or governance of the program, the failure to find a statisti-
cally significant effect (or the success of finding one) may be due to choices
made in the evaluation. To demonstrate the potential limitations and pitfalls of
the usual analytic methods used for estimating causal effects, we apply the first
half of a roadmap for causal inference to a pre-post evaluation of a community-
level, national nutrition program. Selection into the program was non-random
and strongly associated with the pre-treatment (lagged) outcome. Using struc-
tural causal models (SCM), directed acyclic graphs (DAGs) and simulated data,
we demonstrate that a post treatment estimand controls for confounding by the
lagged outcome but not from possible unmeasured confounders. Two separate
difference-in-differences estimands have the potential to adjust for a certain type
of unmeasured confounding, but introduce bias if the additional assumptions they
require are not met. Our results reveal an important issue of identifiability when
estimating the causal effect of a program with pre-post observational data. A care-
ful appraisal of the assumptions underlying the causal model is imperative before
committing to a statistical model and progressing to estimation.
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1. Introduction 
Interventions scaled-up to a large or national level have failed to consistently demonstrate the causal 
benefits anticipated by results of small-scale experimental studies (Engle et al. 2011).  Challenges in 
evaluating a program operating at-scale are not limited to the logistical and technical constraints of 
surveying hundreds to thousands of households across a region or country, but also include the analytic 
process of determining whether the program demonstrates a benefit that actually is the result of the 
program.  Our ability to make a causal claim from an evaluation may easily be compromised by the 
choices we make in the analysis, and are particularly complex in observational studies.  These choices are 
made even more controversial with the availability of pre-treatment outcome data, as we will demonstrate 
in this paper.  Misleading estimates of a program’s benefit (in either direction) have significant policy and 
funding implications for the program, as well as for the people the program is intended to help. 
In an introductory chapter on econometric evaluations of social programs, Nobel laureate James Heckman 
and co-author Edward Vytlacil point out that we often confuse the three main issues that face an 
evaluation: definition, identification and estimation.  The authors state that “particular methods of 
estimation (e.g., matching or instrumental variable estimation) have become associated with ‘causal 
inference’ and even the definition of certain ‘causal parameters’ ...” (Heckman and Vytlacil 2007).  
Investigators from different disciplines will bring distinct theoretical and analytical frameworks to 
estimation, which can lead to differing estimates of the causal effect and contradictory conclusions, in 
some cases without strong theoretical justification for the approach they used.  However, the selection of 
an estimator should happen after defining the research question and causal target parameter, and after the 
underlying assumptions necessary to identify the parameter are made explicit.  In keeping with this logic, 
we divide the evaluation of an existing intervention into two papers.  In this first paper, we work step-by-
step through the first part of a roadmap for causal inference (van der Laan and Rose 2011), and present 
the second half of the roadmap, which includes the methods of estimation and inference, separately. In 
doing so, we hope to underscore the need to “define first, identify second, and estimate last” (quote from 
Judea Pearl’s forward in Targeted Learning by van der Laan and Rose) (van der Laan and Rose 2011; 
Pearl 2010). 
We make use of a program in Madagascar as a backdrop for exploration.  The Madagascar national 
nutrition program presents some interesting challenges that are common in evaluations of large-scale 
interventions.  First, the program was implemented at the community rather than the individual level.  
Community programs differ from individual treatment regimens in that they are typically made available 
to all (or most) residents of a community and sharing of information within a community is often 
encouraged.  Examples of other community programs include national child health days (Alderman 
2007), breast-feeding promotion campaigns (Popkin et al. 1991; Bhutta et al. 2008), and conditional cash 
transfers (Paxson and Schady 2008; Fernald, Gertler, and Neufeld 2008; Macours, Schady, and Vakis 
2008).  When the point of treatment is the community, the research question shifts from the more familiar 
individual-level treatment to what would happen to the community under a given treatment assignment.  
In this context, we need to reframe the question, building up by analogy from the individual to the group. 
We use the potential outcomes framework (also known as the counterfactual framework) popularized by 
the work of  Rubin to help in this regard (Rubin 1973).  In a counterfactual framework, we consider the 
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“ideal experiment” when posing our research question.  For example, what would have happened to a 
given community had it received treatment (the counterfactual) when in fact it had not?   
A second challenge was that the program rollout was non-random: treatment assignment was made in 
such a way that communities with the greatest perceived need were to receive the program first.  
Communities were selected for treatment if they were located within districts with a pre-program 
prevalence of underweight1 that was above the national average, or if they met certain logistical criteria 
(e.g., a local non-profit organization was available to supervise the program).  Non-random assignment of 
treatment makes inferences about the programs’ effect susceptible to confounding if the comparison 
group is not exchangeable with the treated group on key determinants of the outcome.  Therefore, it is 
imperative that we define a causal model for the system that is hypothesized to have generated the data 
and to examine clearly the relations and dependencies of the factors in the model (measured and 
unmeasured).  We use a semi-parametric variant of a structural equation model for our causal model to 
avoid making assumptions about the underlying functional form of the data distribution (Pearl 1995, 
2010).  In addition, we use graphical models (directed acyclic graphs or DAGs) to make the assumptions 
underlying our causal models transparent.  We demonstrate how DAGs can be used for locating sources 
of dependencies among variables. 
Third, cross-sectional surveys were administered in the same communities in Madagascar pre- and post-
intervention, providing multiple options for identification of a causal effect.  In this paper, we contrast the 
definition of the outcome as either: the post treatment value or the change from pre to post treatment.  We 
consider the long-standing controversy over the advantages and disadvantages of each (Imai 2008; Maris 
1998).  Using these two outcomes, we identify three statistical parameters used for interventions with pre-
post data that under different assumptions are equivalent to our causal target parameter of interest.  We 
purposefully include two difference-in-differences models commonly used with pre-post data: a change 
score estimand and a pooled outcome estimand (popular in the social sciences and econometrics) (Meyer 
1994; Gertler et al. 2011; Lord 1956; Imai 2008).  We also include a conventional approach from the 
epidemiology literature in which the pre-intervention outcome (or lagged outcome) is included in the 
conditioning set of covariates.   
Finally, we present a series of data simulations, and show how the estimate of the target causal parameter 
diverges from the truth when the necessary assumptions for a given model fail to hold.  Although the 
context for this paper is specific to the Madagascar study, the process is applicable to any program 
evaluation for which the investigator seeks to interpret an estimated effect of treatment on outcome as a 
causal effect. 
2. Setting & Notation 
In Madagascar, approximately 30% of children under five are estimated to be underweight (UNICEF 
2011).  Underweight is a near-term marker for inadequate nutrition and is estimated to be responsible for 
the largest proportion of the death and disease burden associated with malnutrition (Black et al. 2008).  In 
1999, the Madagascar National Office of Nutrition (ONN) implemented a comprehensive community-
level growth-monitoring and nutrition program, incorporating multiple activities that have been found to 
                                                             
1 Underweight is an indicator of being two standard deviations below the median weight of a reference population 
of well- nourished and healthy children of the same age and gender.  
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be associated with better child outcomes (Galasso and Umapathi 2007).  The project has since expanded 
to include 5550 sites and covers approximately 1.1 million children (or about a third of children under 5 
years of age in Madagascar) (Sharp and Kruse 2011). 
The evaluation of the Madagascar program included a series of repeated cross-sectional, nationally 
representative, anthropometric surveys, administered pre- and post-implementation of the program, in 
both program participating and non-participating communities.  Each survey included different children, 
but the same communities.  The type of data collected is described in general terms in Table 1.  Specifics 
of the data collected are given in our second paper on estimation. 
Table 1: Notation used for variables, parameters, and outcomes 
Notation Description 
V Vector of time invariant community level covariates (e.g., urban location) 
Wc(t) Vector of community level covariates that summarize individual level 
factors, Wi(t), (i=1,…,N), for each of the N individuals sampled in the 
community at time t = 0,1 (e.g., proportion of mothers sampled in the 
community who are uneducated) 
A Treatment, assigned at the community level 
𝑌𝑐(𝑡) = 1
N
�𝑌𝑖(𝑡)N
𝑖=1
 
Community mean of individual level outcomes Yi(t) (i=1,…,N) for each of 
the N individuals sampled in the community at time t = 0,1 (e.g., weight-
for-age of children under 5 years) 
Oj = (Vj, Wcj(t), Aj, 
Ycj(t)) 
Observed data structure, Oj, for a given community j.  The observed data 
are J independently and identically distributed copies of O. 
UV,…UY(t) Random variation for each variable 
P0 True data-generating distribution; Oj ~ P0 
Yca, Yθa Counterfactual outcomes; we focus on 2 outcomes: post treatment 
outcome, Yc(t = 1), and the change in outcome pre and post treatment, Yθ = 
Yc(t = 1) - Yc(t = 0). For each, we define their counterfactual value under 
treatment level A=a (Yca  and Yθa, respectively). 
Ψ(P0) True value of the target statistical parameter (or estimand), consisting of 
parameter mapping Ψ applied to the true data generating distribution P0.  
We present 3 estimands labeled ΨI, ΨII, and ΨIII. 
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Our outcome of interest is community mean weight-for-age2 for children under 5 years, one of the 
primary nutritional outcomes in children targeted by the program, and also a key determinant of the initial 
program implementation.  In a prior analysis of the Madagascar program, the authors found that the 
program reduced the prevalence of child underweight in treated communities during a period of 
worsening malnutrition in non-treated communities (between 1997/98 and 2004) (Galasso and Umapathi 
2009).  We revisit these results in the context of a detailed framework for evaluation. 
We use the notation shown in Table 1 based on the book on Targeted Learning by van der Laan and Rose 
(van der Laan and Rose 2011).  The notation has been modified to indicate how we aggregate individual 
level measures up to the community level (e.g., mean maternal education), and that these are different 
from community variables that are considered time-independent and are measured once for the entire 
group (e.g., geographic location). 
3. Causal Inference Road Map 
The road map we follow links the research question to inference, making the underlying assumptions 
explicit for the path between the two (see van der Laan and Rose, chapters 1 and 2 for more detail) (van 
der Laan and Rose 2011).  First, we define precisely the research question.  This may seem obvious, but is 
often not made clear.  Second, we turn the research question and relevant background knowledge into a 
structural causal model (SCM) (Pearl 2010), which encodes information about the relationships between 
the variables with a series of semi-parametric equations.  Importantly, we assume that the SCM accurately 
represents the data generating processes that gave rise to our observed data.  This is the key link from 
counterfactual to observed data. 
Given the SCM, we specify the causal parameter of interest in the third step.  The causal parameter is the 
parameter we would obtain under an ideal experiment and is defined using counterfactual notation.  A 
clear specification of the causal parameter requires an understanding of the outcome; the variable(s) on 
which we want to intervene; the unit (or level) on which we are intervening; and the counterfactual 
outcome distributions (or parameters of these distributions) we want to compare.  In the Madagascar case, 
we explore two outcomes: a post treatment value and a pre-post change score, and we want to intervene 
on the program availability at the community level (as opposed to program participation by an 
individual).  We use the phrasing “intervening to set the treatment” or “setting A=a” to refer to the 
hypothetical treatment condition that we want to apply to the system when making causal contrasts.   In 
this paper, we are interested in estimating the difference in the expectation (or mean) of counterfactual 
outcomes intervening to set the treatment to 1 (to receive treatment) versus intervening to set the 
treatment to 0 (to not receive treatment), for all communities.  This contrast is known as the average 
treatment effect, or the ATE.  We could evaluate other causal parameters of interest, such as the average 
treatment effect among the treated, or the ATT.  The ATT contrasts the expectation of counterfactual 
outcomes under treatment and no treatment, but only among the treated communities.  Importantly for 
either parameter, the contrast is made between the means of the counterfactual outcomes under each 
treatment regime.  This is a simpler causal comparison than between the two potential outcomes for any 
given community, where one outcome is always unobserved. 
                                                             
2 Weight-for-age z-score are obtained using a reference population of well- nourished and healthy children of the 
same age and gender. 
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In the fourth step, we assess identifiability, or whether the observed data, in combination with our 
assumptions about the data generating system, are sufficient to express the target casual parameter of 
interest as a parameter of the distribution of the observed data alone.  This second parameter is the 
statistical target parameter (also referred to as the estimand; we use the terms interchangeably).  In 
contrast to the causal parameter, the estimand is the parameter that we are able to estimate given the 
observed data.  Because we have pre-post data, we evaluate the assumptions for three different statistical 
target parameters.  In the first estimand, the outcome is defined as the outcome post treatment (Yc(t = 1)); 
in the second, the outcome is defined as the change in outcome pre- vs. post-intervention (Yθ); and in the 
third, the outcome is pooled over time (Yc(t)). 
In the last steps of the roadmap, we can commit to an estimand and statistical model and proceed with the 
estimation.  We will do so in a separate paper, presenting estimation and inference results for the 
observed data from Madagascar.  However, in this paper, we use simulations to illustrate the different 
assumptions required for the three statistical parameters to be equivalent to the average treatment effect 
(ATE), our target parameter of interest, and the consequences when the assumptions do not hold.  Clearly, 
the ATE is just one possible causal parameter of interest that we could have explored, but it is of interest 
in many health studies.  We chose the ATE to demonstrate how selecting a statistical model without 
understanding the underlying assumptions can threaten the validity of a causal effect estimate.  The 
choice of a different causal parameter would not eliminate this threat.  We present detailed steps 1 
through 4 of the roadmap next. 
3.1 Roadmap Steps 1-3: The Research Question, Target Causal Parameter & SCM 
Our causal question is: Does the intervention increase the average nutritional status of children living in 
the community?  In this paper, we are interested in estimating a population average effect at the 
community level, for all communities in the target population. 
The structural causal model (SCM) is characterized by a set of endogenous variables at two time points 
(see notation Table 1).  Community variables that are not aggregates of individual factors are denoted by 
V, and are assumed to be time-invariant for the period of the study.  Individual level factors aggregated up 
to community-level factors are denoted by a vector, Wc(t), at time t.  The community-level mean outcome 
for children at time t is denoted as Yc(t).  The community level exposure, A is assigned to zero or one as a 
function of V, Wc(t = 0) and Yc(t = 0).  In addition, there are unmeasured exogenous variables, U, that may 
cause random variation in each of the observed variables.  Restrictions on the joint distribution of these 
unmeasured errors will be required for identifiability. 
We pose the following SCM to explain the relationships between the variables:  
 
V = fV(UV) 
Wc(t = 0) = fW(t = 0)(V, UW(t = 0))  
Yc(t = 0) = fY(t = 0)(V, Wc(t = 0), UY(t = 0)) 
A = fA(V, Wc(t = 0), Yc(t = 0), UA) 
Wc(t = 1) = fW(t = 1)(V, Wc(t = 0), Yc(t = 0), UW(t = 1)) 
Yc(t = 1) = fY(t = 1)(V, Wc(t = 0), Yc(t = 0), A, Wc (t = 1), UY(t = 1)), 
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where no assumptions are made about the shape or form of the functions.  We start with a model with a 
minimal set of exclusion restriction assumptions about the data-generating system in order to avoid 
imposing restrictions that may, or may not be, supported by the data.  We make a single exclusion 
restriction in this model: that the covariates Wc(t = 1) occurring post intervention are not affected by the 
intervention.  We impose this deliberate exclusion restriction for three reasons.  First, it is a reasonable 
assumption in the context of the Madagascar study.  Second, it is required for the estimand with the 
outcome pooled over time (see identifiability section for estimand III), and we apply it to the other two 
estimands to facilitate our comparison across estimands (although it is not required).  Finally, it allows us 
to condition on Wc(t = 1) in the models to better predict Yc(t = 1) (also not required for the first two 
estimands). 
In the ideal experiment, we would want to know what would happen to the population mean outcome, if 
every community had the program, versus none of the communities had the program.   We translate this 
into our target causal parameter as the average treatment effect (ATE) given by: E(Yc1(t = 1) - Yc0(t = 1)), 
where Yca(t) denotes the counterfactual community level outcome under an intervention on the SCM 
setting A=a.  In the next step, we describe three identifiability results (and corresponding estimands) 
where we link this causal parameter to our observed data distribution. 
3.2 Roadmap Step 4: Assess Identifiability 
Causal effect estimation relies on assumptions, some of which cannot be tested.  These assumptions must 
be made explicit when using observational data for causal inference.  Specifically, the identifiability of 
our causal target parameter requires some form of the following two assumptions to hold: the 
randomization assumption (RA) and the experimental treatment assignment (ETA) assumption.   
The RA (also known as the assumption of no unmeasured confounders, or of exchangeability), states that 
treatment, A, is independent of counterfactual outcome, Ya, given some subset of the data.  The RA is a 
causal assumption, and as such is not testable.  However, we can draw a graphical representation of our 
SCM (i.e., a DAG) to check the independence assumptions given our knowledge of the underlying data 
generating system (Pearl 1995, 2010).  By using a graphical procedure, we are able to solve the 
identification problem without resorting to an algebraic analysis of whether a statistical model parameter 
has a unique solution in terms of the parameters of the distribution of the observed variables (Pearl 2010).  
Detailed guidelines for reading causal diagrams are available in An Introduction to Causal Inference by 
Judea Pearl (Pearl 2010), or in Causal Diagrams for Epidemiological Research by Sander Greenland et. 
Al (Greenland, Pearl, and Robins 1999).  Very briefly, the graph is drawn based on the relationships 
defined in the SCM, where the parents of a variable (variables on the right hand side of the equation) are 
connected to the child variable (variable on the left hand side of the equation) with an arrow directed 
towards it.  A path is any sequence of lines connecting two variables. The arrow between two variables 
can only go in one direction, such that the paths are acyclic (i.e., the graph cannot have A→ B → C →A).  
Paths can either be open or blocked, depending on the direction of the arrows and whether or not a 
variable is conditioned on.  Conditioning on a variable is represented by placing a box around it.  Open 
paths can give rise to dependency between variables, and the absence of any open paths implies marginal 
independence. 
The specific randomization assumption (RA) and necessary additional assumptions for our three 
estimands are discussed in detail below.  To minimize confusion from too many arrows, we represent 
DAGs for each estimand using a simplified data structure that omits the observed, time-invariant, village 
http://biostats.bepress.com/ucbbiostat/paper319
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factors, V.  We justify this simplification because V are exogenous to the data generating system (no 
arrows go into V) and if we condition on V, we do not have to worry about unblocked paths from 
unmeasured variables through V.  In most cases, we also omit the exogenous variables, U, such that Oj = 
(Wc(t), A, Yc(t)).  The omission of the U’s implies that these exogenous variables are independent 
(discussed further with Figure 1).  Paths depicted in red in the figures represent unblocked paths between 
the treatment and outcome variables. 
 
Figure 1: DAG illustrating that post-treatment outcome, Yc(1), is independent of treatment, A, given lagged outcome, Yc(0), pre- 
and post-treatment covariates, Wc(0) and Wc(1), and exogenous covariates, V (not shown).  There are no unmeasured 
confounders. 
The ETA assumption (also known as the positivity assumption) states that for the target statistical 
parameter to be identified there must be sufficient variation in treatment (i.e., some positive probability of 
both being treated and not being treated) within strata of confounders.  The form of the ETA assumption 
depends on knowledge of the data-generating system encoded in the SCM and on the target parameter.  
For the average treatment effect, the strong positivity assumption states that each possible treatment level 
occurs with some positive probability within each stratum of the confounders (Petersen et al. 2011).  But 
this can be weakened under additional parametric assumptions.  For example, urban versus rural location 
is a confounder in our study in Madagascar.  The strong version of the ETA assumption requires that we 
have both treated and untreated, urban and rural communities in our observed data.  If, in fact, there were 
no observed treated urban communities, then we could weaken the ETA assumption by assuming (if 
plausible) that the treatment effect is the same among urban and rural communities.  However, imposing 
this type of parametric assumption is risky as it requires extrapolating from an area supported by the 
observed data (the treatment effect among rural communities) to an area that is not (the treatment effect 
among urban communities) (Petersen et al. 2011). The ETA assumption will be discussed in more detail 
in the next paper in the context of the actual data from Madagascar.  For the purposes of this paper, we 
accept that the ETA assumption is not violated in our study. 
There are two additional assumptions that are typically invoked when investigators start from the Rubin 
framework of potential outcomes for causal inference: the consistency assumption and the stable unit 
treatment value assumption (SUTVA) (Robins, Hernán, and Brumback 2000).  Both assumptions are 
A 
Y
c
(0) 
W
c
(0) W
c
(1) 
Y
c
(1) 
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subsumed in our SCM and the implied knowledge it encodes about the underlying data generating 
distribution.  The consistency assumption states that an individual’s (or community’s) potential outcome 
under the treatment actually received is precisely the observed outcome (Robins, Hernán, and Brumback 
2000).  This assumption is used to convert probabilities written in terms of counterfactuals into ordinary 
probabilities in terms of observed values.  However, our SCM already implies the counterfactual and 
provides the necessary link to the observed data.  In addition, the absence of hierarchical relationships 
between communities in our SCM implies that one community’s (or individual’s) outcome is unaffected 
by another’s treatment assignment (i.e., SUTVA holds). 
3.3 Estimand I: Outcome Yc( t = 1) 
For the first estimand, we define the outcome as the community specific mean post-treatment outcome, 
Yc(t = 1). Identifiability is based on conditioning on all baseline covariates, including the pre-treatment (or 
lagged) outcome (as well as the post treatment covariates Wc(t = 1) assumed not to be affected by A, as 
discussed above).  The randomization assumption for this estimand is: 
 
(1) 𝑌ac(𝑡 = 1) ⊥ 𝐴|𝑉,𝑊c(𝑡 = 0),𝑌c(𝑡 = 0),𝑊c(𝑡 = 1) 
 
For the RA (1) to hold, it is sufficient that the exogenous variables for the exposure, UA, be independent 
of the exogenous variables for the outcome, UY(t = 1), given V, Wc(t = 0), Yc(t = 0), Wc(t = 1).  This 
additional independence assumption is reasonable, if we have no unmeasured common causes of A and 
Yc(t = 1) (i.e., no confounders).   
The DAG in Figure 1 encodes the information from the series of equations from the SCM in the previous 
section.  The graphical model is particularly useful in that we can visually check that Yc(t = 1) is 
independent of A given Wc(t = 0), Yc(t = 0), and Wc(t = 1).  Specifically, we check that our conditioning 
variables block any unblocked path from A to Yc(t = 1) (i.e., paths with arrows pointing into A), while not 
opening any new paths.  This is referred to as the backdoor criterion (Greenland, Pearl, and Robins 1999).  
In Figure 1, the variables Wc(t = 0), Yc(t = 0), and V (not shown) are conditioned on, block the paths from 
A to Yc(t = 1), and satisfy the backdoor criterion.  Writing the graph in this way implies the independence 
assumptions among the exogenous variables, U, described previously.  The RA (1) holds under this 
model.   
We now have the following identifiability result: 
 
E(Yca(t = 1) | V, Wc(t = 0), Yc(t = 0), Wc(t = 1)) = 
E(Yca(t = 1) | A=a, V, Wc(t = 0), Yc(t = 0), Wc(t = 1)) = 
E(Yc(t = 1) | A=a, V, Wc(t = 0), Yc(t = 0), Wc(t = 1)) 
 
where the first equality holds under the RA(1), and the second holds under our definition of the 
counterfactual outcomes.  Note that for these conditional expectations of the outcome to be well-defined 
in our SCM, we need some communities with and without the treatment for each level of the conditioning 
variables V and Wc(t) (i.e., we need for the positivity assumption to hold).   
A first estimand (or statistical parameter) for the average treatment effect, ΨI, follows: 
 
(2) Ψ𝐼(𝑃0) = 𝛦V,W(𝑡 = 0),Y(𝑡 = 0),W(𝑡 = 1) � 𝛦�𝑌c(𝑡 = 1)|𝐴 = 1,𝑉,𝑊c(𝑡 = 0),𝑌c(𝑡 = 0),𝑊c(𝑡 = 1)�−𝛦�𝑌c(𝑡 = 1)|𝐴 = 0,𝑉,𝑊c(𝑡 = 0),𝑌c(𝑡 = 0),𝑊c(𝑡 = 1)�� 
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We refer to this estimand as the post treatment estimand. 
3.4 Estimand II: Outcome Yθ 
Next, we consider the outcome as the change in the community specific means, Yθ, before and after 
treatment.  We define Yθ as: 
 
(3) Yθ = Yc(t = 1) – Yc(t = 0) 
 
By definition of the structural equations for Yc(t = 1) and Yc(t = 0), we have the following structural 
equation for Yθ: 
 
Yθ = fY(t = 1)(V, Wc(t = 0), Yc(t = 0), A, Wc(t = 1), UY(t = 1)) - fY(t = 0)(V, Wc(t = 0), UY(t = 0)) 
 
 
Figure 2: DAG illustrating that pre-post change outcome, Yθ, is independent of treatment, A, given the lagged outcome, Yc (0), 
pre- and post-treatment covariates, Wc(0) and Wc(1), and exogenous covariates, V (not shown).  There are no unmeasured 
confounders. 
The DAG in Figure 2 reflects this same information.  Note that UY(t = 0) now affects both Yc(t = 0) and Yθ, 
so we have included it in the graph.  Under this model, we have a new RA for outcome, Yθ: 
 
(4) Yθa A | V, Wc(t = 0), Yc(t = 0), Wc(t = 1) 
 
and we can identify a statistical target parameter based on Yθ that is equivalent to ΨI (Rubin, Stuart, and 
Zanutto 2004).  Specifically, if we define the counterfactual mean of Yθa under an intervention on the 
SCM setting A=a as: 
 
(5) E(Yθa) = E(Yca(t = 1) - Yca(t = 0))= E(Yca(t = 1)) - E(Yca(t = 0)) 
 
then we can rewrite our target causal parameter in terms of Yθa, and show that it is identical to the ATE as 
previously defined as E(Yc1(t = 1) - Yc0(t = 1)).  First, the parameter is expressed as a difference in the 
differences of means: 
 
(6) E(Yθ1 - Yθ0) = (E(Yc1(t = 1)) – E(Yc1(t = 0))) - (E(Yc0(t = 1)) – E(Yc0(t = 0))) 
⊥
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However, since intervening to set the treatment cannot affect the pre-treatment outcome (Yca(t = 0)= Yc(t 
= 0)), the above can be rewritten such that the mean of Yc(t = 0) cancels out to give the ATE: 
 
(7) (E(Yc1(t = 1)) – E(Yc(t = 0))) - (E(Yc0(t = 1)) – E(Yc(t = 0))) = E(Yc1(t = 1) – Yc0(t = 1)) 
 
Under the RA (4), we can identify our statistical target parameter  
 
E(Yθa | V, Wc(t = 0), Yc(t = 0), Wc(t = 1)) = 
E(Yθa | A=a, V, Wc(t = 0), Yc(t = 0), Wc(t = 1)) = 
E(Yθ | A=a, V, Wc(t = 0), Yc(t = 0), Wc(t = 1)) 
 
and have an alternative, but equivalent, formulation of estimand ΨI: 
 
(8)  ΨI
∗(𝑃0) = EV,W(t=0),Y(t=0),W(t=1) � E �𝑌θ|𝐴 = 1,𝑉,𝑊C(𝑡 = 0),𝑌C(𝑡 = 0),𝑊C(𝑡 = 1)�
−𝐸 �𝑌θ|𝐴 = 0,𝑉,𝑊C(𝑡 = 0),𝑌C(𝑡 = 0),𝑊C(𝑡 = 1)�� 
 
So what is the advantage of using Yθ over Yc(t = 1) for estimating the ATE?  The main justification in the 
causal inference literature is that a difference method allows for both the treatment, A, and outcome, Yc(t), 
to depend on unobserved community fixed effects that are time invariant (Allison 1990; Imai 2008).  To 
explore this advantage, we add an unmeasured confounder, C = fC(UC), to our SCM and DAG, such that C 
is a common cause for A, Yc(t = 0), and Yc(t = 1) (see Figure 3).  The allowed functional forms of fY(t = 0) 
and fY(t = 1) in the SCM are restricted such that C has a linear additive effect on Yc(t), specifically that: 
 
Yc(t = 0) = fY(t = 0)(V, Wc(t = 0), UY(t = 0)) + C 
 
Yc(t = 1) = fY(t = 1)(V, Wc(t = 0), Yc(t = 0), A, Wc(t = 1), UY(t = 1)) + C 
 
 
Figure 3: DAG illustrating that an unblocked path (i) is opened from treatment, A, to the the post-treatment outcome, Yc(1), in the 
presence of unmeasured confounder, C.  
The introduction of an unmeasured confounder, C, opens up a backdoor path from A to Yc(t = 1) (see path 
A ← C → Yc(t = 1) labeled (i) and colored red in Figure 3).  The RA (1) for estimand I no longer holds.  
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At first, it appears that RA(4) might hold for Yθ.  If we assume C has a constant additive effect on both 
Yc(t = 0) and Yc(t = 1), then Yθ is not a function of C when taking the difference of Yc at the two time 
points.  The structural equation for Yθ remains unchanged in this case. 
 
The DAG for Yθ in Figure 4 reflects this same information in that there is no arrow from C into Yθ (only 
variables on the right hand side of the equation have arrows into Yθ).  Thus using Yθ instead of Yc(t = 1) as 
outcome has the potential (under this specific parametric assumption) to close one backdoor pathway 
from A to Yθ via unmeasured confounder C. 
 
Figure 4: DAG illustrating by conditioning on pre-treatment outcome, Yc(0), in the presence of unmeasured confounder, C, that 
an unblocked path (ii) is opened from treatment, A, to the pre-post change outcome, Yθ, through C and exogenous UY(t = 0). 
However, on closer inspection, RA (4) does not hold under this model.  Under the causal model where C 
affects Yc(t = 0), Yc(t = 1), and A, conditioning on Yc(t = 0) induces new dependence between Yθ and A, 
and opens a backdoor path through exogenous variable UY(t = 0) and confounder C.  This occurs because 
Yc(t = 0) is a collider (two arrows go into the same variable).  Conditioning on a collider opens a path that 
would otherwise be blocked.(Pearl 1995)  This unblocked path, A ←C − UY(t = 0) → Yθ, is represented by 
the line between UY(t = 0) and C (labeled (ii) in Figure 4).  The path would be blocked if Yc(t = 0) is not 
conditioned on. 
Thus, to benefit from the potential to remove unmeasured confounding from the use of Yθ as outcome, we 
need a new RA (9), which is not conditional on Yc(t = 0): 
 
(9) Yθa A | V, Wc(t = 0), Wc(t = 1) 
 
It is important to note that we have arrived at the same conclusion with DAGs that others have reached 
using parametric equations and analysis of covariance.  In the econometrics literature, the problem is 
recognized as the fact that the residual on Yθ (in a parametric equation) is necessarily correlated with the 
lagged outcome, Yc(t = 0), because both are a function of the random error on Yc(t = 0) (i.e., a function of 
UY(t = 0) in our SCM) (Angrist and Pischke 2009).  Conditioning on Yc(t = 0) has been demonstrated to bias 
the treatment effect estimate under this model where the errors on Yc are serially correlated (Angrist and 
Pischke 2009).  The method of differencing can still be applied if this correlation is thought to be 
⊥
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negligible (i.e., possibly when the data are from a series of cross-sections of different individuals and/or 
the time between cross-sections is long) (Guryan 2004).  However, RA (9) still does not hold under this 
model without additional assumptions.  We make these assumptions apparent with the use of the DAG 
shown in Figure 5. 
By not conditioning on Yc(t = 0), we open up multiple new pathways from A to Yθ: directly through Yc(t = 
0) (A←Yc(t = 0)→Yθ,  labeled (iii) in Figure 5);  through C (A←C→Yc(t = 0)→Yθ, labeled (iv)); and 
through UY(t = 0) (A←Yc(t = 0)←UY(t = 0)→Yθ, labeled (v)).  Additionally, Wc(t = 1) is a descendant of 
collider Yc(t = 0), and conditioning on Wc(t = 1) opens up the same pathway as conditioning on Yc(t = 0) 
(i.e., A ←C − UY(t = 0)→ Yθ).  However, if we do not condition on Wc(t = 1), then we would open up new 
backdoor pathways through Wc(t = 1) (i.e., A←C→Yc(t = 0)→Wc(t = 1)→Yθ and A←Yc(t = 0)→Wc(t = 
1)→Yθ  labeled (vi)). 
 
Figure 5: DAG illustrating by not conditioning on lagged outcome, Yc(0), in the presence of unmeasured confounder, C, that 
multiple unblocked paths are opened from treatment, A, to the pre-post change outcome, Yθ, through: (iii) lagged outcome, Yc(0); 
(iv) confounder, C;  (v) exogenous UY(t = 0); and (vi) collider covariates Wc(1). 
Therefore, we must be willing to make three additional exclusion restrictions for our casual parameter to 
be identifiable in a difference model:  that Yc(t = 0) must not affect A, Wc(t = 1) and Yc(t = 1).  The semi-
parametric equation for Yθ becomes: 
 
Yθ = Yc(t = 1)-Yc(t = 0) = fY(t = 1)(V,Wc(t = 0), A, Wc(t = 1), UY(t = 1)) - fY(t = 0)(V,Wc(t = 0), UY(t = 0)) 
 
where Yθ is no longer a function of Yc(t = 0) but is still a function of UY(t = 0) (see Figure 6).   Under this 
model, we can choose to either adjust for Wc(t = 1) or not (conditioning on Wc(t = 0) is sufficient and Wc(t 
= 1) is no longer a descendant of a collider). 
In summary, RA (9) holds in the presence of unmeasured confounding from non-time varying factors, C, 
with a constant additive effect on Yc(t), only if Yc(t = 0) does not affect A, Yc(t = 1) and Wc(t = 1). The 
target causal parameter can now be identified as a new target parameter of the observed data distribution. 
The identifiability result applied to Yθ becomes: 
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E(Yθa | V, Wc(t = 0), Wc(t = 1)) = 
E(Yθa | A=a, V, Wc(t = 0), Wc(t = 1)) = 
E(Yθ | A=a, V, Wc(t = 0), Wc(t = 1)) 
 
where the first equality holds under the RA (9) and the second from the definition of the counterfactual 
outcome Yθ  under our new SCM (Figure 6), giving us a new estimand for the ATE, ΨII: 
 
(10) ΨII(𝑃0) = 𝐸V,W(t=0),W(t=1) � E �𝑌θ|𝐴 = 1,𝑉,𝑊C(𝑡 = 0),𝑊C(𝑡 = 1)�
−E �𝑌θ|𝐴 = 0,𝑉,𝑊C(𝑡 = 0),𝑊C(𝑡 = 1)�� 
 
which we refer to as the change score estimand. 
 
Figure 6: DAG illustrating exclusion restrictions on lagged outcome Yc (0) for the pre-post change outcome, Yθ, in the presence of 
unmeasured confounder, C.  Yθ, is independent of treatment, A, given covariates, only if Yc(0), does not affect treatment, A,  post-
treatment outcome, Yc(1), and post-treatment covariates, Wc(1). 
3.5 Estimand III: Outcome Yc( t) 
Finally, there is an alternate difference-in-differences estimand that pools the outcome data from both 
time periods together.  For this approach, we need to evaluate a third causal model for identifiability.  
Specifically, if we are willing to make additional assumptions on the underlying causal model such that: 
 
(11) EV,W(t = 1),W(t = 0)(Yc(t) | A=a, V, Wc(t = 0),Wc(t = 1)) = EV,W(t)(Yc(t) | A=a, V, Wc(t)), for t =0, 1 
 
then we have the following identifiability result under the new SCM: 
 
E(Yθa | V, Wc(t = 0), Wc(t = 1)) = 
E(Yθa | A=a, V, Wc(t = 0), Wc(t = 1)) = 
E(Yc(t = 1) | A=a, V, Wc(t = 0), Wc(t = 1)) – E(Yc(t = 0) | A=a, V, Wc(t = 0), Wc t = 1)) = 
E(Yc(t = 1) | A=a, V, Wc(t = 1)) – E(Yc(t = 0) | A=a, V, Wc(t = 0)) 
 
As with estimand II, the first equality in the identifiability result holds under the RA (9).  The last equality 
holds under assumption (11) (i.e., by substituting t = 1 and t = 0 for t), giving us a third estimand for the 
ATE: 
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(12) 
ΨIII(𝑃0) = 𝐸V,W(t) � E �𝑌C(𝑡 = 1)|𝐴 = 1,𝑉,𝑊C(𝑡 = 1)� − E �𝑌C(𝑡 = 0)|𝐴 = 1,𝑉,𝑊C(𝑡 = 0)�
−E �𝑌C(𝑡 = 1)|𝐴 = 0,𝑉,𝑊C(𝑡 = 1)� − E �𝑌C(𝑡 = 0)|𝐴 = 0,𝑉,𝑊C(𝑡 = 0)�� 
 
We refer to this final estimand as the pooled outcome estimand.  However, there may be additional 
restrictions on the allowed data distribution for this identifiability result to hold.  Starting with the SCM 
established for the change score estimand (ΨII), we work through the model separately at each time point.  
At time t = 1, assumption (11) becomes: 
 
EV,W(t = 1),W(t = 0)(Yc(t = 1) | A=a, V, Wc(t = 0),Wc(t = 1)) = EV,W(t=1)(Yc(t = 1) | A=a, V, Wc(t = 1)), 
 
which will hold if Yc(t = 1) is independent of Wc(t = 0) given V, A, and Wc(t = 1).  We can use the DAG 
shown in Figure 7 to check whether our SCM implies this conditional independence.  Under our current 
model, assumption (11) fails at t = 1 because of two unblocked paths: the direct path from Wc(t = 0) to 
Yc(t = 1) (label (vii) in Figure 7); and the paths through collider A (i.e., Wc(t = 0) – C→Yc(t = 1) label (viii) 
in Figure 7).  Therefore, for assumption (11) to hold at t = 1, we need to add two new exclusion 
restrictions: that Wc(t = 0) does not affect Yc(t = 1) and does not affect A (see Figure 8).  
 
Figure 7: DAG illustrating the test of independence for the pooled outcome estimand at time t=1 in the presence of unmeasured 
confounder, C.  Two unblocked paths are opened from pre-treatment covariates, Wc(0), to post-treatment outcome, Yc(1): (vii) 
through a direct path; and (viii) the path through C created by the collider treatement, A. 
Similarly, at time t = 0, assumption (11) becomes: 
 
EV,W(t = 1),W(t = 0)(Yc(t = 0) | A=a, V, Wc(t = 0),Wc(t = 1)) = EV,W(t=0)(Yc(t = 0) | A=a, V, Wc(t = 0)) 
 
and we verify with a DAG that our SCM implies Yc(t = 0) is independent of Wc(t = 1) given V, A, and Wc(t 
= 0) (Figure 9).  No additional exclusion restrictions are required. 
Note that we cannot add any arrows back that were removed for estimand II (i.e., Yc(t = 0) cannot affect 
A, Wc(t = 1) or Yc(t = 1)).  Under the additional restriction assumptions that Wc(t = 0) does not affect A and 
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Yc(t = 1), our causal target parameter, the ATE, is equivalent to estimand III.   In settings where 
background knowledge makes it plausible to assume this more restrictive causal model, alternative 
estimation approaches offer some important advantages over traditional approaches, which will be 
discussed in the next paper. 
 
Figure 8: DAG illustrating exclusion restrictions on pre-treatment covariates Wc(0) for the pooled outcome estimand at time t=1 
in the presence of unmeasured confounder, C.  The post-treatment outcome, Yc(1), is independent of Wc(0) given treatment, A, 
and post-treatment covariates, Wc(1), only if Wc(0) does not affect Yc(1) and does not affect A. 
 
Figure 9: DAG illustrating exclusion restrictions on pre-treatment covariates Wc(0) for the pooled outcome estimand at time t=0 
in the presence of unmeasured confounder, C.  The lagged outcome, Yc(0), is independent of post-treatment covariates, Wc (1), 
given treatment, A, and Wc( (0), if Wc(0) does not affect post-treatment outcome, Yc(1), and does not affect A. 
4. Illustration of Results Using Simulated Data  
In this section, we present a series of simulations to demonstrate the need for the additional exclusion 
restrictions for the difference-in-differences estimands (ΨII and ΨIII).  The programming language R, 
version 2.13.1, was used for the simulations (the code is available in the Appendix).  As with the DAGs, 
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we exclude the observed village factors, V, from the simulations.  We present eight scenarios based on 
different SCMs represented by the DAGs in the previous section.  In all cases, Yc(t), Wc(t) and C are 
continuous, normally distributed and a function of additive linear terms.  Treatment variable, A, is 
dichotomous and the true parameter of interest, the ATE, has a value of 1.  For each scenario and 
estimand, linear regression with main terms was used to estimate the relevant conditional expectation 
from a sample of 100,000 observations.  These estimates are reported in Table 2.     
The first simulation is based on the starting SCM for the post treatment estimand (ΨI) represented in 
Figure 1.  Under this model, RA (1) holds.  We obtain identical estimates of the target parameter whether 
the outcome is defined as Yc(t = 1) or Yθ (Figure 2 and RA (4)).  The estimate is nearly equal to the target 
parameter value of 1 (simulation #1, Table 2).  However, when we introduce an unmeasured confounder, 
C, in the second simulation, RA (1) and RA (4)  no longer hold and the estimate diverges from the truth 
(simulation #2).  This result is in keeping with a backdoor pathway being open from A to outcome Yc(t = 
1) through C (path (i) in Figure 3) or with dependence between Yθ and A through UY(t = 0) and confounder 
C (path (ii) in Figure 4).  
Table 2: Estimates3 for the ATE under various models and sample size (true value =1) 
Sim #4 Figure Assumptions Conditional 
on Yc(t = 0)5 
Estimate 
1 1 & 2 RA (1) or (4), no unmeasured confounders,  
A does not affect Wc(t = 1) 
Yes ΨI 
0.99 
2 3 & 4 RA (1) or (4) with unmeasured confounder C, A 
does not affect Wc(t = 1) 
Yes ΨI 
3.43 
3 5 RA (9) with unmeasured confounder C,  
A does not affect Wc(t = 1),  
Yc(t = 0) affects A, Wc(t = 1), and Yc(t = 1) 
No ΨII 
4.78 
4 6 RA (9) with unmeasured confounder C,  
A does not affect Wc(t = 1), and 
Yc(t = 0) does not affect A, Wc(t = 1), or Yc(t = 1)  
No ΨII 
0.98 
5 N/A Same as simulation 4 but Yc(t = 0) affects A No ΨII -1.78 
6 7 RA (9) with unmeasured confounder C,  
A does not affect Wc(t = 1), 
Yc(t = 0) does not affect A, Wc(t = 1), or Yc(t = 1) 
Assumption (11) but 
Wc(t = 0) affects A and Yc(t = 1) 
No ΨIII 
6.64 
7 8 & 9 RA (9) with unmeasured confounder C,  
A does not affect Wc(t = 1),  
Yc(t = 0) does not affect Wc(t = 1), A, or Yc(t = 1) 
Assumption (11), and 
Wc(t = 0) does not affect A or Yc(t = 1) 
No ΨIII 
1.02 
8 N/A Same as simulation 7 but Yc(t = 0) affects A No ΨIII -0.99 
 
                                                             
3 Conditional expectation from a sample of 100,000 observations for a specified scenario and estimand using linear 
regression with main terms 
4 Reference number for the simulation scenario described in the text 
5 Indicator of whether or we conditioned on Yc(t=0)  in the simulation  
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Switching to our change score estimand (ΨII), we demonstrate that the estimate for the ATE diverges 
from 1 when not conditioning on Yc(t = 0) (simulation #3) because it opens up new pathways from A to Yθ 
(paths (iii) to (vi) in Figure 5).  By adding the necessary exclusion restrictions for estimand II in the fourth 
simulation (i.e., Figure 6), the estimate once again nearly equals the target value (simulation #4).  These 
results are comparable to those for the post treatment estimand with no unmeasured confounding 
(simulation #1).  However, in simulation #5, we add that Yc(t = 0) affects A into the previous scenario for 
estimand II.  In this fifth scenario, estimand II will diverge from the truth.   
The sixth simulation represents the model for our pooled outcome estimand (ΨIII), where at time t = 1, Yc(t 
= 1) is not independent of Wc(t = 0) given V, A, and Wc(t = 1) (Figure 7).  As expected, the estimate for 
estimand III diverges from 1 (simulation #6).   However, when the paths from Wc(t = 0) to A and Yc(t = 1) 
are removed (Figure 8), estimand III is equal to the ATE (simulation #7).  Finally, in simulation #8, we 
add that Yc(t = 0) affects A into the previous scenario for estimand III, and the estimate once again 
diverges from the truth.  As with simulation #5, this last simulation demonstrates that even if we can 
accept all the other exclusion restrictions for estimand III, we still must be willing to accept that Yc(t = 0) 
does not affect A for the difference-in-differences estimands to equal the target parameter.  
In summary, the above simulations show that when there is an unmeasured confounder, the post treatment 
estimand is not equal to the ATE whereas the change score and pooled outcome estimands might be, but 
only under additional assumptions.  We demonstrate that even with an additive constant confounder C, 
we can get into trouble by using these latter two estimands (ΨII and ΨIII) if Yc(t = 0) affects A (i.e., Yc(t = 
0) is a confounder).   
5. Discussion 
Pre-post program evaluations (with data from treatment and control groups) present investigators with 
multiple causal models to choose from for identifying a causal effect of the program.  Causal assumptions 
are necessary to obtain a valid estimate of a casual effect, and each of these models relies on a different 
set of assumptions.   However, the causal model needs to be defined before committing to a statistical 
model (as opposed to selecting an estimand based on the estimation procedure it allows).  In this paper, 
we use the structure of an existing program evaluation with pre-post data as the basis for defining several 
commonly used causal models.  First we define the outcome as the post treatment value, Yc(t = 1), and 
present a causal model that requires a minimal set of exclusion restriction assumptions for identification 
of the ATE (estimand I).  Under the key assumption of no unmeasured confounding, the simple post 
treatment estimand (ΨI) equals our target parameter (simulation #1 in table 1).  As expected, ΨI and the 
ATE diverge (i.e., are no longer equal) if an unmeasured factor, C, is introduced that confounds the 
relationship between treatment and outcome (simulation #2). 
Since unmeasured cofounding is a realistic scenario in observational studies, it is not surprising that a 
difference-in-differences approach is often favored to try to address this issue.  A differencing model is 
advantageous in that it “subtracts out” the effect of unmeasured confounders with a constant additive 
effect on the outcome at the two time points.  The commonly accepted identifying assumption for the 
difference-in-differences estimand is a randomization assumption (RA (9)) typically referred to in the 
econometrics literature as the parallel trend assumption.  However, through a step-by-step process of 
checking graphical models, we show that several exclusion restrictions are necessary for the difference-
in-differences estimand to equal the ATE.  In order to take advantage of this approach, we must be willing 
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to assume that the lagged outcome, Yc(t = 0), does not affect treatment, A, the post-treatment covariates, 
Wc(t = 1), or the post-treatment outcome, Yc(t = 1).  These are very strong assumptions about the lagged 
outcome!  Under conditions where these restrictions do not hold, ΨII and ΨIII will generally not be 
equivalent to the ATE (as illustrated with simulations #3, 5, 6, and 8).  In fact, a difference-in-differences 
estimand has the potential to diverge further from the wished for causal effect than the post treatment 
estimand adjusting for all baseline covariates, even in the presence of an unmeasured confounder with a 
constant additive effect. 
The exclusion restrictions become more numerous for the model that pools the outcome from both time 
periods (ΨIII).  In order for the pooled outcome estimand to be equal to the causal parameter of interest, 
we must add to the list of assumptions for the change score estimand (ΨII) that Wc(t = 0) does not affect A 
or Yc(t = 1). 
Although the exclusion restriction assumptions for  difference-in-differences models may seem 
unrealistic, it is important to note that they are often applied to data from serial cross-sections of different 
persons from the same communities separated in time by many years (Guryan 2004).  It is possible under 
certain conditions that the pre-intervention outcome and covariates do not directly affect the post-
intervention outcome and covariates, and are associated with post intervention outcome and covariates 
due only to fixed community level factors that affect both.  In other words, Yc(t = 0) may be predictive of 
Yc(t = 1), but only due to shared common causes C or V.  The advantage of controlling for unmeasured 
fixed effects with a difference-in-differences estimand must be weighed against what is known about the 
underlying data generating system and the associated model assumptions.  
In this paper, we demonstrate the power (and importance) of using graphical models (DAGs) to make the 
assumptions underlying a causal model transparent.  The graphs prove to be invaluable tools for locating 
sources of dependencies among variables from confounders or colliders that may result in bias.   Ideally, 
researchers should spend the time working with DAGs prior to conducting a study in order to collect the 
necessary data for a valid analysis.  In an ex-post facto evaluation, it falls to the analyst to make use of 
DAGs, expert opinion, and other tools at their disposal, before proceeding with estimation.  For example, 
given that the statistical model is semi-parametric, some of the exclusion restrictions are testable (i.e., that 
Yc(t = 1) is independent of Wc(t = 0) given A, Wc(t = 1) and V). 
6. Conclusions 
This paper might be more accurately titled: “To ignore or not to ignore the unobservables? That is the 
question.”  Although different disciplines control for observed confounders in different ways, we all agree 
that we should control for them in the best way possible.  However, disagreement runs deep with respect 
to those factors that we do not observe.  In the Madagascar evaluation, we are faced with a bias trade-off 
between a single post-treatment estimand that conditions on the pre-treatment outcome (a measured 
confounder) but assumes no unmeasured confounders, and two difference-in-differences estimands that 
address certain types of unmeasured confounders but do not condition on the pre-treatment outcome.  The 
following is a re-phrasing of text from an article that compares two methods (one from epidemiology, one 
from econometrics) in such a way that it speaks to this bias trade-off (Hogan and Lancaster 2004).  An 
economist will view the single post-treatment estimand with suspicion because the assumption of no 
unmeasured confounders seems unrealistic.  On the other hand, an epidemiologist or biostatistician will 
be wary of the difference-in-differences estimands that purport to “subtract out” a variable that has not 
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been (and possibly cannot be) observed.  In reality, both rely on assumptions that cannot be empirically 
verified. 
Given that the unobservables may also be unknown, how should we decide whether to ignore them or 
not?  The authors of this same article have a take on the disciplinary differences that we find helpful: 
“… Many epidemiologic studies differ from those in social sciences in that the collection of 
candidate confounders is an integral part of study design. By contrast, important research 
questions in economics and the social sciences are usually addressed by analysing data that have 
been collected or are maintained by government agencies or survey organizations (e.g., Current 
Population Survey, Medicaid data, etc.). The databases serve as important resources for 
investigating a wide variety of issues, but the variables are not typically selected for a specific 
research agenda. Consequently, econometric methods for causal inference are predicated on the 
existence of at least one and possibly several unmeasured confounding variables; therefore, 
confounding is essentially viewed as an omitted variables problem that leads to correlation 
between errors and covariates (endogeneity)...”(Hogan and Lancaster 2004) 
In the absence of a third alternative (to ignore, not to ignore, other?), we conclude that the answer to the 
question lies in part with the source of the data, and in part with what is known about the data generating 
system.  Consider the situation where information is collected on known confounders, for a well-defined 
research question, based on expert knowledge and the use of SCMs and DAGs.  In this case, ignoring 
unobserved variables may be the best choice because the measurement of confounders was integral to the 
study and we can do a good job of controlling for them.  We also avoid imposing additional untestable 
restrictions on the data.  In the alternate situation where the research question is defined after the data 
were collected (e.g., from a national government survey), using a model that averages away the 
unobservables may be the better choice (again based on the research question, expert knowledge and 
DAGs).   
Epidemiologists who use survey data collected for another purpose than their own can learn an important 
lesson from economists in choosing a statistical model for evaluation.  For example, suppose an analyst 
wants to evaluate the effect of the national school lunch program on obesity among children in the U.S. 
using publically available data.  The methods used by economists to evaluate labor or other policies may 
be necessary to account for unmeasured factors that may have influenced selection into the school lunch 
program.  Similarly, economists who plan detailed measurement into their survey design a priori can 
learn an important lesson from epidemiologists.   By incorporating DAGs into the planning process, 
researchers can identify a sufficient set of observables that should be measured to control for 
confounding.  In this way, we can avoid models that only hold under assumptions that may be 
implausible. 
In summary, our results reveal an important issue of identifiability that is not clearly articulated in the 
published literature.  In the context of evaluating a community level intervention with pre-post data, we 
are confronted with a trade-off between statistical models that require expert knowledge about the 
observed data before choosing one over the other.  Specifically, the SCM should incorporate expert 
knowledge about the data generating process that gave rise to the observed data.  Any assumptions 
necessary to obtain a valid estimate of the desired causal effect should be reflected in the SCM and 
supported by this knowledge. The step of evaluating the assumptions for a given study should not be 
Hosted by The Berkeley Electronic Press
20 
 
overlooked prior to selecting a model and proceeding with estimation.  Failure to do so can result in 
choosing an estimand that is not equivalent to the target casual parameter. 
If our knowledge is sufficient to accurately represent the underlying data generating distribution, then our 
casual model may help us choose between estimands (e.g., whether the post treatment estimand is closer 
to the ATE than the pooled outcome estimand).  In many cases, however, our knowledge will be 
insufficient and we won’t know that the SCM holds for either estimand (or know which estimand is closer 
to our target parameter).  Importantly, if we have strong evidence that a) there is important unmeasured 
confounding, and that b) the data do not support any other assumptions on which our identifiability results 
rely, then the target parameter is not identifiable.  We cannot disregard this evidence; we risk obtaining a 
biased estimate.  Instead, it is at this juncture that we must consider redefining our research question and 
target parameter before proceeding.  The threat to validity from selecting a statistical model without 
understanding the underlying assumptions transcends our work and is applicable to any evaluation of an 
intervention. 
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Appendix: R Code for Simulations 
 
R Code for simulations 1-6: 
#------------------------ 
# In all, I assume W1 is not affected by A, and exclude observed exogenous variables, V 
#------------------------ 
set.seed(100) 
n <- 100000 
C<-rnorm(n,0,4) 
W0<-rnorm(n,0,4) 
#------------------------ 
# Run 1: Example for figure 3.1: estimand I, controlling for Y0 
# No unmeasured confounding C  
Y0<-rnorm(n,0.5*W0,4) 
A<-rbinom(n,1,1/(1+exp(-0.5*W0-0.5*Y0))) 
W1<-rnorm(n,W0+Y0,4) 
Y1<-rnorm(n,W0+2*Y0+A+W1,4) 
est1 <- glm(Y1~A+W0+W1+Y0) 
#------------------------------------------- 
# Run 2: Example for figure 3.3: estimand I 
# Introduce unmeasured confounder C that affects Y(0), Y(1) and A 
Y0<-rnorm(n,0.5*W0+C,4) 
A<-rbinom(n,1,1/(1+exp(-0.5*W0-0.5*Y0-0.5*C))) 
W1<-rnorm(n,W0+Y0,4) 
Y1<-rnorm(n,W0+Y0+A+W1+C,4) 
est2 <- glm(Y1~A+W0+W1+Y0) 
#------------------------------------------- 
# Run 3: Example for figure 3.5: estimand II, not controlling for Y(0) 
# Unmeasured confounder C 
Y0<-rnorm(n,0.5*W0+C,4) 
A<-rbinom(n,1,1/(1+exp(-0.5*W0-0.5*Y0-0.5*C))) 
W1<-rnorm(n,W0+Y0,4) 
Y1<-rnorm(n,W0+Y0+A+W1+C,4) 
Yd<-Y1-Y0 
est3 <- glm(Yd~A+W0+W1) 
#------------------------------------------- 
# Run 4: Example for figure 3.6: estimand II, not controlling for Y(0) 
# Confounder C, assume Y(0) does not affect A, W(1), or Y(1); i.e., no confounding by Y(0) 
Y0<-rnorm(n,0.5*W0+C,4) 
A<-rbinom(n,1,1/(1+exp(-0.5*W0-0.5*C))) 
W1<-rnorm(n,W0,4) 
Y1<-rnorm(n,W0+A+W1+C,4) 
Yd<-Y1-Y0 
est4 <- glm(Yd~A+W0+W1) 
#------------------------------------------- 
# Run 5: Example for figure 3.7: estimand III 
# Confounder C, assume Y(0) does not affect A, W(1), or Y(1); i.e., no confounding by Y(0) 
# Assumption (11) but W(0) affects A and Y(1) 
Y0<-rnorm(n,0.5*W0+C,4) 
A<-rbinom(n,1,1/(1+exp(-0.5*W0-0.5*C))) 
W1<-rnorm(n,W0,4) 
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Y1<-rnorm(n,W0+A+W1+C,4) 
# Reshape wide to long 
id <- paste("id", 1:n, sep="") 
data_wide <- data.frame(id,C,A,W0,Y0,W1,Y1) 
data_long <- reshape(data_wide, 
  varying = 4:7, 
 idvar = "id", 
 direction = "long", 
 timevar = "T", 
 new.row.names = NULL, 
 sep = "") 
est5 <- glm(Y~A+W+T+A*T,data=data_long) 
#------------------------------------------- 
# Run 6: Example for figure 3.8: estimand III 
# Confounder C, assume Y(0) does not affect A, W(1), or Y(1); i.e., no confounding by Y(0) 
# Assumption (11) and W(0) does not affect A or Y(1) 
Y0<-rnorm(n,0.5*W0+C,4) 
A<-rbinom(n,1,1/(1+exp(-0.5*C))) 
W1<-rnorm(n,W0,4) 
Y1<-rnorm(n,A+W1+C,4) 
# Reshape wide to long 
id <- paste("id", 1:n, sep="") 
data_wide <- data.frame(id,C,A,W0,Y0,W1,Y1) 
data_long <- reshape(data_wide, 
  varying = 4:7, 
 idvar = "id", 
 direction = "long", 
 timevar = "T", 
 new.row.names = NULL, 
 sep = "") 
est6 <- glm(Y~A+W+T+A*T,data=data_long) 
#------------------------------------------- 
# Run 7: Example adding Y(0) affects A into run 4 
Y0<-rnorm(n,0.5*W0+C,4) 
A<-rbinom(n,1,1/(1+exp(-0.5*W0-0.5*Y0-0.5*C))) 
W1<-rnorm(n,W0,4) 
Y1<-rnorm(n,W0+A+W1+C,4) 
Yd<-Y1-Y0 
est7 <- glm(Yd~A+W0+W1) 
#------------------------------------------- 
# Run 8: Example adding Y(0) affects A into run 6 
Y0<-rnorm(n,0.5*W0+C,4) 
A<-rbinom(n,1,1/(1+exp(-0.5*Y0-0.5*C))) 
W1<-rnorm(n,W0,4) 
Y1<-rnorm(n,A+W1+C,4) 
# Reshape wide to long 
id <- paste("id", 1:n, sep="") 
data_wide <- data.frame(id,C,A,W0,Y0,W1,Y1) 
data_long <- reshape(data_wide, 
  varying = 4:7, 
 idvar = "id", 
http://biostats.bepress.com/ucbbiostat/paper319
25 
 
 direction = "long", 
 timevar = "T", 
 new.row.names = NULL, 
 sep = "") 
est8 <- glm(Y~A+W+T+A*T,data=data_long) 
#------ 
est_all <-rbind(est1$coeff["A"],est2$coeff["A"],est3$coeff["A"],est4$coeff["A"], 
est5$coeff["A:T"],est6$coeff["A:T"],est7$coeff["A"],est8$coeff["A:T"]) 
est_all 
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